Furthermore, inhibition of ALDOA activity by using a pharmacological inhibitor or silencing leads to the death of cancer cells due to disruption of the integrity of their actin cytoskeleton, which is dependent on aldolase activity (Gizak et al., 2019). Here, ALDOA is linked to cancer.